Trial intelligence / Profile preview

Synergies between WS 1070 and structured stress management in patients with fatigue and decreased concentration under subjective stress

2010-022114-12Phase 4Completed

Sponsor
Schwabe Group
Start
Sep 2010
Countries
1
01

Overview

Phase 4, randomised, open-label trial of WS 1070 in asthenia and None (3 arms), sponsored by Schwabe Group. Started Sep 2010; status: completed.

02

Drugs

WS 1070
03

Conditions

asthenia

Beyond the preview

Go deeper on 2010-022114-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022114-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call